Shogo Nakamoto
7PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 14, 2024
Radiation hepatitis after postmastectomy radiation therapy for early breast cancer: difficult to differentiate from drug-induced liver injury caused by abemaciclib.Shogo Nakamoto, Takahiro Waki, Asuka Mimata
|Apr 29, 2024
Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer.Shogo Nakamoto, Tadahiko Shien, Takayuki Iwamoto
|Oct 31, 2023
Systemic immunity markers are associated with clinical outcomes of atezolizumab treatment in patients with triple-negative advanced breast cancer: a retrospective multicenter observational study.Shogo Nakamoto, Tadahiko Shien, Mitsuya Itoh
|Jan 04, 2022
Eribulin improved the overall survival from the initiation of first-line chemotherapy for HER2-negative advanced breast cancer: a multicenter retrospective study.Shogo Nakamoto, Junichiro Watanabe, Shoichiro Ohtani
|Nov 03, 2021
Shorter duration of first-line chemotherapy reflects poorer outcomes in patients with HER2-negative advanced breast cancer: a multicenter retrospective study.Shogo Nakamoto, Junichiro Watanabe, Shoichiro Ohtani
|May 09, 2021
Leptomeningeal Metastasis in ER + HER2- Advanced Breast Cancer Patients: A Review of the Cases in a Single Institute Over a 15-year Period.Junichiro Watanabe, Koichi Mitsuya, Shogo Nakamoto
Pageof 2
